We have located links that may give you full text access.
Primary Mechanism of Stroke Reduction in Transcarotid Artery Revascularization is Dynamic Flow Reversal.
Journal of Vascular Surgery 2020 December 2
OBJECTIVE: Recent studies have suggested that the low risk of stroke and death associated with TransCarotid Artery Revascularization (TCAR) is partially attributable to a robust dynamic flow reversal system as well as the avoidance of the atherosclerotic aortic arch during the stenting procedure. However, the benefit of flow reversal compared to distal embolic protection (DEP) in reducing stroke or death in transcarotid revascularization has not been studied.
METHODS: All patients undergoing carotid artery stenting via the transcarotid route with either dynamic flow reversal (TCAR) or DEP (TCAS_DEP) in the Vascular Quality Initiative from September 2016 to November 2019 were analyzed. Both multivariable logistic regression and nearest neighbor propensity score matched analysis were performed to explore differences in outcomes between the two procedures. Differences in outcomes were tested with McNemar test. The primary outcome was in-hospital stroke or death. Secondary outcomes were stroke, death, myocardial infarction (MI), and stroke, death or MI. A secondary analysis was preformed comparing transcarotid stenting with DEP vs transfemoral carotid stenting with DEP to evaluate the impact of crossing the aortic arch.
RESULTS: A total of 8,426 patients were identified (TCAS_DEP: 287; 3.4%). TCAR was associated with a lower risk of in-hospital stroke/death (1.6% vs 5.2%; OR: 0.35 [95% CI: 0.20-0.64]; P=0.001), stroke (1.4% vs 4.2%; OR: 0.37 [95% CI: 0.20-0.68]; P=0.002), and stroke/death/MI (2.0% vs 5.2%; OR: 0.41 [95% CI: 0.23-0.71]; P=0.001) compared to TCAS_DEP. Among the 274 pairs of patients identified with propensity score matching, TCAR was associated with a lower risk of stroke/death (1.1% vs 4.7%; RR: 0.23 [95% CI 0.06-0.81]; P=0.021) and stroke (0.4% vs 4.0%; RR: 0.09 [95% CI 0.01-0.70]; P=0.006) compared to TCAS_DEP but no differences in stroke/death/MI (1.8 vs 4.7%; , RR: 0.38 [95% CI: 0.15-1.02]; P=0.077). The secondary analysis found that there was no difference in stroke between TCAS_DEP and transfemoral carotid stenting with DEP (4.9% vs 3.7%, RR: 1.3 [95% CI: 0.36-1.63]; P=0.65).
CONCLUSIONS: Compared with TCAS_DEP, TCAR was associated with a lower risk of perioperative stroke or death and stroke. This implies dynamic flow reversal may be a better neuroprotection system than distal embolic filter in reducing the perioperative risk of stroke. Avoiding the aortic arch did not confer any reduction in stroke rate. This study serves to separate the clinical benefit of dynamic flow reversal from that of avoiding the aortic arch in TCAR.
METHODS: All patients undergoing carotid artery stenting via the transcarotid route with either dynamic flow reversal (TCAR) or DEP (TCAS_DEP) in the Vascular Quality Initiative from September 2016 to November 2019 were analyzed. Both multivariable logistic regression and nearest neighbor propensity score matched analysis were performed to explore differences in outcomes between the two procedures. Differences in outcomes were tested with McNemar test. The primary outcome was in-hospital stroke or death. Secondary outcomes were stroke, death, myocardial infarction (MI), and stroke, death or MI. A secondary analysis was preformed comparing transcarotid stenting with DEP vs transfemoral carotid stenting with DEP to evaluate the impact of crossing the aortic arch.
RESULTS: A total of 8,426 patients were identified (TCAS_DEP: 287; 3.4%). TCAR was associated with a lower risk of in-hospital stroke/death (1.6% vs 5.2%; OR: 0.35 [95% CI: 0.20-0.64]; P=0.001), stroke (1.4% vs 4.2%; OR: 0.37 [95% CI: 0.20-0.68]; P=0.002), and stroke/death/MI (2.0% vs 5.2%; OR: 0.41 [95% CI: 0.23-0.71]; P=0.001) compared to TCAS_DEP. Among the 274 pairs of patients identified with propensity score matching, TCAR was associated with a lower risk of stroke/death (1.1% vs 4.7%; RR: 0.23 [95% CI 0.06-0.81]; P=0.021) and stroke (0.4% vs 4.0%; RR: 0.09 [95% CI 0.01-0.70]; P=0.006) compared to TCAS_DEP but no differences in stroke/death/MI (1.8 vs 4.7%; , RR: 0.38 [95% CI: 0.15-1.02]; P=0.077). The secondary analysis found that there was no difference in stroke between TCAS_DEP and transfemoral carotid stenting with DEP (4.9% vs 3.7%, RR: 1.3 [95% CI: 0.36-1.63]; P=0.65).
CONCLUSIONS: Compared with TCAS_DEP, TCAR was associated with a lower risk of perioperative stroke or death and stroke. This implies dynamic flow reversal may be a better neuroprotection system than distal embolic filter in reducing the perioperative risk of stroke. Avoiding the aortic arch did not confer any reduction in stroke rate. This study serves to separate the clinical benefit of dynamic flow reversal from that of avoiding the aortic arch in TCAR.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app